Value of measurement of antinuclear antibodies, antiphospholipid antibodies and antineutrophil cytoplasmic antibodies in the diagnostic classification of early onset chronic inflammatory arthritis without clinicals signs

Revue du Rhumatisme (Edition Francaise)

Volumn 69, Issue 2, 2002, Pages 139-146

  Hachulla, Éric ^a   De Bandt, Michel ^b   Dubucquoi, Sylvain ^c   Vittecoq, Olivier ^d   Le Loët, Xavier ^d   Meyer, Olivier ^e  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c UNIV LILLE   (France)

^d ROUEN UNIVERSITY HOSPITAL   (France)

^e BICHAT HOSPITAL   (France)

Author keywords

Antineutrophil cytoplasmic antibodies; Antinuclear antibodies; Antiphospholipid antibodies; Early arthritis

Indexed keywords

ANTINUCLEAR ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; PHOSPHOLIPID ANTIBODY;

ARTICLE; CLINICAL FEATURE; DERMATOMYOSITIS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOFLUORESCENCE; MIXED CONNECTIVE TISSUE DISEASE; POLYARTHRITIS; RHEUMATOID ARTHRITIS; SCLERODERMA; SENSITIVITY AND SPECIFICITY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0036190532     PISSN: 11698330     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1169-8330(01)00267-8     Document Type: Article

References (50)

1. Clinical significance of antinuclear antibodies. Comparison of detection with immunofluorescence and enzyme-liinked immunosorbent assays
2. The use of laboratory tests in the diagnosis of LES
3. Utilization and predictive value of laboratory tests in patients referred to rheumatologists by primary care physicians
4. Range of antinuclear antibodies in «healthy» individuals
5. Is high titre ANA specific for connective tissue disease?
6. Autoantibodies predicting the outcome of rheumatoid arthritis: Evaluation in two subsets of patients according to severity of radiographic damage
7. Pratique et interprétation des examens biologiques dans les maladies systémiques
8. Clinical evaluation of various selected Elisa kits for the detection of anti-DNA antibodies
9. Détection des anticorps anti-ADN natif pour le diagnostic du lupus érythémateux disséminé. Étude comparative des méthodes immunoenzymatiques et d'un test de Farr
10. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases. Antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus
11. Diagnostic value of nucleosome specific antibodies in recent active non treated LES
12. Comparisons of double immunodiffusion, Elisa, western blot and CAPE blot for the detection of anti-SSA antibody: Study of anti-SSA prevalence in systemic lupus erythematosus
13. The detection of anti-Ro/SS-A and anti-La/SS-B antibodies. A comparison of counterimmunoelectrophoresis with immunoblot, Elisa, and RNA-precipitation assays
14. Ro/SSA and La/SSB specific IgA autoantibodies in serum of patients with Sjögren's syndrome and systemic lupus erythematosus
15. Clinical significance of anti-R (SSA) antibody in rheumatoid arthritis
16. Anti-R (SSA) antibodies in patients with rheumatoid arthritis-a possible marker for gold induced side effects
17. Les anticorps anti-Ro/SS-A. Du berceau (du nouveauné) au lit (du malade), la route passe par la paillase (du fondamentaliste)
18. Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients
19. Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: Their specificity for LES and association with IgG anticardiolipin antibodies
20. Syndrome des antiphospholipides. Encycl Méd Chir (éditions Scientifiques et Médicales Elsevier SAS, Paris, tous droits réservés)
21. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus
22. Anticardiolipin antibodies in unselected autoimmune rheumatic disease patients
23. Anticardiolipin antibodies and physical disability in the elderly
24. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Report of an international workshop
25. Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies
26. Influence of disease duration, continued follow-up and further antiphospholipid testing on the frequency and classification category of antiphospholipid syndrome in a cohort of patients with systemic lupus erythematosus
27. Antiphospholipid antibodies and RA: Presence of β2GP1 independent aCL
28. Anticorps anti-β-glycoprotéine 1 et polyarthrite rhumatoïode [résumé]
29. Prospective evaluation of the frequency and clinical significance of antineutrophil cytoplasmic and anticardiolipin antibodies in community cases of patients with rheumatoid arthritis
30. Antiphoslipid antibodies in primary Sjögren's syndrome: Prevalence and clinical in a series of 80 patients
31. Prévalence des anticorps antiphospholipides dans la maladie de Horton et dans la pseudopolyarthrite rhizomélique
32. Anticardiolipin antibody levels predict flares and relapses in patients with gian-cell (temporal) arteritis. A longitudinal study of 5! biopsy-proven cases
33. Anticardiolipin antibodies in childhood rheumatic disorders
34. Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (LES) and in non-LES disorders. Prevalence and clinical significance
35. Phospholipid specificity of autoimmune and drug induced lupus anticoagulants; association of phosphatidylethanolamine reactivity with thrombosis in autoimmune disease
36. Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: A prospective study
37. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients
38. Treatment of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: Where do we stand?
39. Les autoanticorps «anticytoplasme des polynucléaires» (ANCA): Description et rôle immunopathologique
40. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: Metaanalysis with a focus on antimyeloperoxidase antibodies
41. Antineutrophil cytoplasmic antibodies: A still-growing class of autoantibodies in inflammatory disorders
42. Occurrence of antineutrophil cytoplasmic and antineutrophil (peri) nuclear antibodies in rheumatoid arthritis
43. Antineutrophil cytoplasmic antibodies in patients with early rheumatoid arthritis: An early marker of progressive erosive disease
44. Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus: Prevalence, antigen specificity, and clinical associations
45. Anti-neutrophil cytoplasmic antibody in patients with systemic lupus erythematosus is unrelated to clinical features
46. Minocycline-induced autoimmune syndromes: An overview
47. Evaluation of antineutrophil cytoplasmic antibody seroconversion induced by minocycline, sulfasalazine or penicillamine
48. Antineutrophil cytoplasmic antibody in patients with primary Sjögren's syndrome
49. Antineutrophil anticytoplasmic antibodies in primary Sjögren's syndrome: Prevalence and clinical significance
50. Insuffisance rénale rapidement progressive. Une complication rare du syndrome de Sjögren primaire